PECAM-1 is Associated WithOutcomes and Response to Treatment in Pulmonary Arterial Hypertension

Am J Cardiol. 2020 Jul 15:127:198-199. doi: 10.1016/j.amjcard.2020.04.031. Epub 2020 Apr 29.

¹ Section of Cardiology, Department of Internal Medicine, Yale University, New Haven, CT, USA. Electronic address: katharine.clapham@yale.edu.
² United Therapeutics Corporation, Research Triangle Park, Raleigh, NC, USA.
³ Weill Cornell Medical College, Institute of Academic Medicine, Houston Methodist Hospital, Houston, TX, USA.
⁴ Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Yale University, New Haven, CT, USA.
⁵ Division of Pulmonary, Allergy & Critical Care Medicine, Department of Internal Medicine, Duke University, Durham, NC, USA; Durham Veteran Affairs Medical Center, Durham, NC, USA.
⁶ Inova Heart and Vascular Institute, Falls Church, VA, USA.
⁷ Section of Cardiology, Department of Internal Medicine, Yale University, New Haven, CT, USA.

No abstract available

Publication types